3D eye-surface testing for severe dry eye
Part of Eyes & vision clinical trials.
This study looks at how a specific eye-surface marker (EMMPRIN) changes on the surface cells in people with severe dry eye. It may help researchers understand disease severity and how new treatments could work for severe symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have severe dry eye symptoms and test results (grade 3 or 4)
- Have no eye treatment, or have long-term stable eye treatment with a new treatment being added
- Be able to have eye tests done for dryness (like tear break-up time and staining tests)
- If you are pregnant or breastfeeding, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special eye scan (OCT) to measure the tear film in healthy adults and in people with dry eye. It may help researchers understand what’s different in dry eye and how well the scan reflects dry eye symptoms.
This trial tests a new eye drop (FBV_01) compared to a standard hyaluronic acid eye drop for people with moderate to severe dry eye. The goal is to see if the new drop provides better relief.
This study uses a special microscope to look at the surface of your eye to help doctors better diagnose dry eye disease. If you have dry eye symptoms or healthy eyes, you may be able to join.
This study looks at tiny chemical patterns in tear fluid to better understand different causes of eye surface problems. Your participation may help researchers compare healthy eyes with conditions like dry eye, infections, or allergies.
This study helps doctors find better ways to treat severe dry eye disease. Researchers will perform eye exams and ask questions to understand your condition better and optimize your care.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
Hear when a new Dry Eye Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.